Detalhe da pesquisa
1.
The dual CCR5 and CCR2 inhibitor cenicriviroc does not redistribute HIV into extracellular space: implications for plasma viral load and intracellular DNA decline.
J Antimicrob Chemother
; 70(3): 750-6, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25433008
2.
Identification of an env-defective HIV-1 mutant capable of spontaneous reversion to a wild-type phenotype in certain T-cell lines.
Virol J
; 11: 177, 2014 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25287969
3.
Basis for early and preferential selection of the E138K mutation in HIV-1 reverse transcriptase.
Antimicrob Agents Chemother
; 57(10): 4681-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23856772
4.
Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load.
Antimicrob Agents Chemother
; 56(8): 4154-60, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22615275
5.
Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes.
J Infect Dis
; 201(8): 1155-63, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20214475
6.
Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.
J Virol
; 83(3): 1422-32, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19019970
7.
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic.
J Med Chem
; 62(10): 4851-4883, 2019 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516990
8.
SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
Retrovirology
; 5: 94, 2008 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18928523
9.
Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor.
Antivir Chem Chemother
; 24(1): 28-38, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149264
10.
The value of HIV protective epitope research for informed vaccine design against diverse viral pathogens.
Expert Rev Vaccines
; 13(8): 935-7, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24964950
11.
Exposure to entry inhibitors alters HIV infectiousness and sensitivity to broadly neutralizing monoclonal antibodies.
J Acquir Immune Defic Syndr
; 67(1): 7-14, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24872133
12.
Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques.
PLoS One
; 8(9): e75556, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24098702
13.
R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models.
PLoS One
; 5(7): e11689, 2010 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20657739
14.
Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival.
Vaccine
; 27(12): 1825-33, 2009 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-19201387
15.
Passive immunization as tool to identify protective HIV-1 Env epitopes.
Curr HIV Res
; 5(6): 642-55, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18045119